Cat.#: ACPP-1309
| Despition | CCR5 Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1187 | 5HT1A Blocking Peptide (AC1187) | 250 µg | inquiry |
| ACPP-1470 | Human CLTA Protein (AC1470) | 5 µg | inquiry |
| ACPP-1840 | Human ALDH1A1 Protein (AC1840) | 5 µg | inquiry |
| ACPP-1240 | PAX5 Blocking Peptide (AC1240) | 250 µg | inquiry |
| ACPP-1755 | Human PDGFD Protein (AC1755) | 5 µg | inquiry |
| ACPP-1445 | Human RAB4A Protein (AC1445) | 2 µg | inquiry |
| ACPP-1292 | Nkx2.2 Blocking Peptide (AC1292) | 250 µg | inquiry |
| ACPP-1680 | Human DOK4 Protein (AC1680) | 5 µg | inquiry |
| ACPP-1350 | Presenilin 2 Blocking Peptide (AC1350) | 250 µg | inquiry |
| ACPP-1279 | NEDD4 Blocking Peptide (AC1279) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.